Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum

[1]  P. D'athis,et al.  Urinary β2-microglobulin early indicator of high dose cisdiamminedichloroplatinum nephrotoxicity? Influence of furosemide , 2004, Cancer Chemotherapy and Pharmacology.

[2]  P. Gill,et al.  Nonlinear renal clearance of ultrafilterable platinum in patients treated with cis-dichlorodiammineplatinum (II) , 2004, Cancer Chemotherapy and Pharmacology.

[3]  A. Donker,et al.  Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function , 2004, Cancer Chemotherapy and Pharmacology.

[4]  B. Sikic,et al.  Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion , 2004, Cancer Chemotherapy and Pharmacology.

[5]  P. D'athis,et al.  Model independent pharmacokinetic study of cis-dichlorodiammineplatinum (II). , 1985, International journal of clinical pharmacology, therapy, and toxicology.

[6]  R. Finley,et al.  Cisplatin Nephrotoxicity: A Summary of Preventative Interventions , 1985, Drug intelligence & clinical pharmacy.

[7]  D. Kelsen,et al.  Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations. , 1985, American journal of clinical oncology.

[8]  G. Duggin,et al.  Mechanisms of renal excretion of cisdichlorodiamine platinum. , 1983, Research communications in chemical pathology and pharmacology.

[9]  F. Lévi,et al.  Cisplatin urinary pharmacokinetics and nephrotoxicity: a common circadian mechanism. , 1982, Cancer treatment reports.

[10]  P. Daley-Yates,et al.  The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid. , 1982, Biochemical pharmacology.

[11]  N. Bachur,et al.  High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity. , 1981, Cancer treatment reports.

[12]  T. F. Patton,et al.  Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II). , 1979, Cancer treatment reports.

[13]  A. Guarino,et al.  Platinate toxicity: past, present, and prospects. , 1979, Cancer treatment reports.

[14]  R. Gray,et al.  The effect of diuretic pre-treatment on clinical, morphological and ultrastructural cis-platinum induced nephrotoxicity. , 1979, International journal of radiation oncology, biology, physics.

[15]  M. Pera,et al.  Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum-(II) in rats. , 1979, Cancer research.

[16]  W. Kramer,et al.  Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis. , 1979, Cancer treatment reports.

[17]  R. Golbey,et al.  High dose Cis‐platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis , 1977, Cancer.

[18]  J. Ward,et al.  Prevention of renal failure in rats receiving cis-diamminedichloroplatinum(II) by administration of furosemide. , 1977, Cancer research.